NCT05794022Recruiting
Cohort of STEMI Patients 2
CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in ST Elevation Myocardial Infarction
Source: ClinicalTrials.gov · Last updated 14 May 2026
Brief summary (registry, in English)
ST-segment elevation myocardial infarction (STEMI) is an acute condition that accounts for 75% of sudden deaths in adults over 35 years of age and more than half of all cases of chronic heart failure. However, the mechanism of myocardial infarction remains poorly understood. At present, there is no national information system for myocardial infarction, as there is for other diseases such as multiple sclerosis (OFSEP cohort). The purpose of this cohort is to enable studies and research projects to be carried out on the descriptive epidemiology of myocardial infarction, monitoring of patients undergoing treatment (safety, efficacy), quality of life and functional consequences of infarction, and research into new biological and imaging prognostic biomarkers. Its general objective is to provide researchers, hospital practitioners, medical interns, academics or industrialists with a quality epidemiological tool for research.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 6 Feb 2023
- Start date
- 3 May 2023
- Primary completion date
- 3 Jun 2033
- Lead sponsor
- Hospices Civils de Lyon
- Diseases
- Coronary artery disease
- NCT number
- NCT05794022
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 3 May 2023 to the primary completion date, 3 Jun 2033
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Obvious contraindication to injected magnetic resonance imaging (claustrophobia, pacemaker, defibrillator, or a metallic body (ferromagnetic), severe renal insufficiency (GFR\<30 ml/min), known allergy to the contrast medium ....)
Age
- Pregnant woman or woman of childbearing age without effective contraception, breastfeeding woman.
Other
- Diagnosis of STEMI not confirmed on angiography
- Inability to give the subject informed information
- Lack of coverage by a social security scheme
- Deprivation of civil rights (curators, guardianship, safeguard of justice)
Who the study is looking for
- Age ≥ 18 years
- Diagnosis of STEMI defined by ST segment elevation ≥ 0.2 mV in 2 contiguous leads on a 12-lead ECG.
- Management in primary ACT
- Prior oral informed consent followed by signed informed consent as soon as possible.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospices Civils de Lyon - Hopital Louis Pradel Coordinator of this site? Confirm its status | Bron | France | Recruiting |
| Hospices Civils de Lyon - Hôpital de la Croix Rousse Coordinator of this site? Confirm its status | Lyon | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.